While the potential involvement of IL-1R in IL-1α’s therapeutic effects remains to be confirmed in vivo, our in vitro results suggest a complex mechanism of action that could shed light on why IL-RA stroke therapy has met with mixed success. The gene discussed is IL1A; the disease is stroke disorder.